Jason Kolbert
Stock Analyst at D. Boral Capital
(1.19)
# 2,971
Out of 4,666 analysts
138
Total ratings
30.7%
Success rate
-15.12%
Average return
Main Sectors:
Stocks Rated by Jason Kolbert
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
FBLG FibroBiologics | Maintains: Buy | $16 | $2.32 | +591.14% | 5 | Nov 20, 2024 | |
BMEA Biomea Fusion | Maintains: Buy | $128 | $6.41 | +1,896.88% | 4 | Nov 19, 2024 | |
ANIX Anixa Biosciences | Maintains: Buy | $10 | $3.09 | +223.62% | 6 | Nov 19, 2024 | |
IBRX ImmunityBio | Maintains: Buy | $30 | $5.01 | +498.86% | 3 | Nov 19, 2024 | |
GOVX GeoVax Labs | Maintains: Buy | $18 | $2.71 | +564.60% | 7 | Nov 19, 2024 | |
CRVO CervoMed | Initiates: Buy | $34 | $10.05 | +238.48% | 1 | Nov 18, 2024 | |
LCTX Lineage Cell Therapeutics | Initiates: Buy | $3 | $0.67 | +348.23% | 1 | Nov 18, 2024 | |
RVPH Reviva Pharmaceuticals Holdings | Maintains: Buy | $15 | $1.25 | +1,100.00% | 3 | Nov 14, 2024 | |
MRNS Marinus Pharmaceuticals | Maintains: Buy | $3 | $0.31 | +879.11% | 5 | Nov 13, 2024 | |
HOTH Hoth Therapeutics | Maintains: Buy | $5 | $0.87 | +471.89% | 3 | Nov 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 | $4.58 | +402.18% | 5 | Nov 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 | $1.83 | +555.74% | 2 | Nov 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 | $0.93 | +980.96% | 7 | Nov 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 | $0.18 | +3,295.59% | 5 | Nov 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 | $4.46 | +460.54% | 4 | Nov 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 | $0.85 | +2,722.20% | 3 | Nov 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 | $0.67 | +4,241.32% | 3 | Nov 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 | $2.86 | +634.27% | 5 | Nov 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 | $1.05 | +1,519.05% | 4 | Nov 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 | $11.34 | +120.46% | 5 | Nov 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 | $0.74 | +580.27% | 1 | Nov 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 | $8.28 | +455.56% | 3 | Oct 31, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $0.78 | +1,060.24% | 1 | Oct 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 | $1.22 | +2,442.65% | 2 | Oct 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 | $6.62 | +217.22% | 3 | Oct 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $1.43 | +528.54% | 1 | Oct 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 | $2.02 | +396.28% | 4 | Oct 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 | $1.67 | +1,161.26% | 3 | Oct 3, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $1.15 | +421.74% | 1 | Oct 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 | $1.00 | +1,200.00% | 3 | Sep 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $4.33 | +269.52% | 1 | Sep 24, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 | $4.06 | +244.83% | 2 | Aug 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 | $0.98 | +514.75% | 1 | Aug 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $96 | $0.20 | +47,074.45% | 1 | Feb 28, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.42 | - | 2 | Aug 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $457 → $1,314 | $0.20 | +659,207.58% | 1 | Feb 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $120 | $1.16 | +10,289.61% | 1 | Jan 30, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $0.13 | +4,487.16% | 1 | Jan 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.01 | - | 2 | Nov 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.34 | - | 1 | Sep 16, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.44 | - | 1 | Jul 18, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.73 | - | 1 | Oct 13, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $40 | $0.80 | +4,900.00% | 1 | Mar 17, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $32 | $1.03 | +3,021.95% | 8 | Nov 6, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $720 → $480 | $3.49 | +13,673.31% | 2 | Jul 28, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Terminates: Sell | n/a | $6.93 | - | 4 | Jun 15, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.03 | - | 2 | Mar 6, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $135 | $1.26 | +10,614.29% | 1 | Aug 17, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $0.55 | - | 2 | May 18, 2017 |
FibroBiologics
Nov 20, 2024
Maintains: Buy
Price Target: $16
Current: $2.32
Upside: +591.14%
Biomea Fusion
Nov 19, 2024
Maintains: Buy
Price Target: $128
Current: $6.41
Upside: +1,896.88%
Anixa Biosciences
Nov 19, 2024
Maintains: Buy
Price Target: $10
Current: $3.09
Upside: +223.62%
ImmunityBio
Nov 19, 2024
Maintains: Buy
Price Target: $30
Current: $5.01
Upside: +498.86%
GeoVax Labs
Nov 19, 2024
Maintains: Buy
Price Target: $18
Current: $2.71
Upside: +564.60%
CervoMed
Nov 18, 2024
Initiates: Buy
Price Target: $34
Current: $10.05
Upside: +238.48%
Lineage Cell Therapeutics
Nov 18, 2024
Initiates: Buy
Price Target: $3
Current: $0.67
Upside: +348.23%
Reviva Pharmaceuticals Holdings
Nov 14, 2024
Maintains: Buy
Price Target: $15
Current: $1.25
Upside: +1,100.00%
Marinus Pharmaceuticals
Nov 13, 2024
Maintains: Buy
Price Target: $3
Current: $0.31
Upside: +879.11%
Hoth Therapeutics
Nov 13, 2024
Maintains: Buy
Price Target: $5
Current: $0.87
Upside: +471.89%
Nov 13, 2024
Maintains: Buy
Price Target: $23
Current: $4.58
Upside: +402.18%
Nov 12, 2024
Maintains: Buy
Price Target: $12
Current: $1.83
Upside: +555.74%
Nov 12, 2024
Maintains: Buy
Price Target: $10
Current: $0.93
Upside: +980.96%
Nov 11, 2024
Maintains: Buy
Price Target: $6
Current: $0.18
Upside: +3,295.59%
Nov 11, 2024
Maintains: Buy
Price Target: $25
Current: $4.46
Upside: +460.54%
Nov 11, 2024
Maintains: Buy
Price Target: $24
Current: $0.85
Upside: +2,722.20%
Nov 7, 2024
Maintains: Buy
Price Target: $29
Current: $0.67
Upside: +4,241.32%
Nov 7, 2024
Maintains: Buy
Price Target: $21
Current: $2.86
Upside: +634.27%
Nov 7, 2024
Maintains: Buy
Price Target: $17
Current: $1.05
Upside: +1,519.05%
Nov 6, 2024
Maintains: Buy
Price Target: $25
Current: $11.34
Upside: +120.46%
Nov 1, 2024
Maintains: Buy
Price Target: $5
Current: $0.74
Upside: +580.27%
Oct 31, 2024
Maintains: Buy
Price Target: $46
Current: $8.28
Upside: +455.56%
Oct 30, 2024
Initiates: Buy
Price Target: $9
Current: $0.78
Upside: +1,060.24%
Oct 30, 2024
Maintains: Buy
Price Target: $31
Current: $1.22
Upside: +2,442.65%
Oct 15, 2024
Maintains: Buy
Price Target: $21
Current: $6.62
Upside: +217.22%
Oct 14, 2024
Initiates: Buy
Price Target: $9
Current: $1.43
Upside: +528.54%
Oct 10, 2024
Maintains: Buy
Price Target: $10
Current: $2.02
Upside: +396.28%
Oct 3, 2024
Maintains: Buy
Price Target: $21
Current: $1.67
Upside: +1,161.26%
Oct 1, 2024
Initiates: Buy
Price Target: $6
Current: $1.15
Upside: +421.74%
Sep 26, 2024
Maintains: Buy
Price Target: $13
Current: $1.00
Upside: +1,200.00%
Sep 24, 2024
Initiates: Buy
Price Target: $16
Current: $4.33
Upside: +269.52%
Aug 20, 2024
Maintains: Buy
Price Target: $14
Current: $4.06
Upside: +244.83%
Aug 13, 2024
Maintains: Buy
Price Target: $6
Current: $0.98
Upside: +514.75%
Feb 28, 2024
Initiates: Buy
Price Target: $96
Current: $0.20
Upside: +47,074.45%
Aug 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $3.42
Upside: -
Feb 6, 2023
Maintains: Buy
Price Target: $457 → $1,314
Current: $0.20
Upside: +659,207.58%
Jan 30, 2023
Initiates: Buy
Price Target: $120
Current: $1.16
Upside: +10,289.61%
Jan 6, 2023
Initiates: Buy
Price Target: $6
Current: $0.13
Upside: +4,487.16%
Nov 11, 2022
Downgrades: Neutral
Price Target: n/a
Current: $2.01
Upside: -
Sep 16, 2022
Downgrades: Neutral
Price Target: n/a
Current: $0.34
Upside: -
Jul 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $1.44
Upside: -
Oct 13, 2021
Downgrades: Neutral
Price Target: n/a
Current: $0.73
Upside: -
Mar 17, 2021
Downgrades: Neutral
Price Target: $40
Current: $0.80
Upside: +4,900.00%
Nov 6, 2020
Maintains: Buy
Price Target: $33 → $32
Current: $1.03
Upside: +3,021.95%
Jul 28, 2020
Downgrades: Neutral
Price Target: $720 → $480
Current: $3.49
Upside: +13,673.31%
Jun 15, 2018
Terminates: Sell
Price Target: n/a
Current: $6.93
Upside: -
Mar 6, 2018
Downgrades: Hold
Price Target: n/a
Current: $3.03
Upside: -
Aug 17, 2017
Maintains: Buy
Price Target: $120 → $135
Current: $1.26
Upside: +10,614.29%
May 18, 2017
Upgrades: Buy
Price Target: n/a
Current: $0.55
Upside: -